Whalen Wealth Management Inc. Neurocrine Biosciences Inc Transaction History
Whalen Wealth Management Inc.
- $159 Billion
- Q2 2025
A detailed history of Whalen Wealth Management Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Whalen Wealth Management Inc. holds 3,629 shares of NBIX stock, worth $455,802. This represents 0.29% of its overall portfolio holdings.
Number of Shares
3,629
Previous 3,394
6.92%
Holding current value
$455,802
Previous $375 Million
21.51%
% of portfolio
0.29%
Previous 0.25%
Shares
3 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.1MCall Options Held
800KPut Options Held
565K-
Black Rock Inc. New York, NY14.2MShares$1.78 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.25 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$695 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$611 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$335 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...